Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1401–1420 of 17,529 recalls

January 18, 2024· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: Fexofenadine Hydrochloride Tablets

The Issue: CGMP Deviations: Microbial contamination was reported in stagnant

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
January 17, 2024· Henry Schein Inc. and Glove Club HSI Gloves Inc.

Recalled Item: Adrenalin (epinephrine) Injection 1mg/mL

The Issue: Labeling: Incorrect or Missing Lot and/or Exp Date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
January 16, 2024· Ascend Laboratories, LLC

Recalled Item: Fosfomycin Tromethamine Granules for Oral Solution

The Issue: Failed Impurities/Degradation Specification: Out of specification for organic

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 16, 2024· Den-Mat Holdings, LLC

Recalled Item: Hydrogen Peroxide Oral Rinse

The Issue: CGMP Deviations: products may not conform to the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 16, 2024· Den-Mat Holdings, LLC

Recalled Item: OralProCare medicated lip treatment

The Issue: CGMP Deviations: products may not conform to the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 15, 2024· Amneal Pharmaceuticals of New York, LLC

Recalled Item: Phenoxybenzamine Hydrochloride Capsules

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 12, 2024· Neptune Resources, LLC

Recalled Item: Neptune's Fix

The Issue: Marketed without an approved NDA/ANDA: Product contains tianeptine,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 12, 2024· Neptune Resources, LLC

Recalled Item: Neptune's Fix

The Issue: Marketed without an approved NDA/ANDA: Product contains tianeptine,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 12, 2024· Neptune Resources, LLC

Recalled Item: Neptune's Fix

The Issue: Marketed without an approved NDA/ANDA: Product contains tianeptine,

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
January 12, 2024· Golden State Medical Supply Inc.

Recalled Item: Budesonide Extended-Release Tablets

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 12, 2024· IntegraDose Compounding Services LLC

Recalled Item: Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride

The Issue: Subpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 11, 2024· Amerisource Health Services LLC

Recalled Item: Rifampin Capsules USP

The Issue: Failed Impurities/Degradation Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 11, 2024· Par Sterile Products LLC

Recalled Item: Vasostrict (vasopressin in 5% Dextrose) Injection

The Issue: Superpotent Drug: Assay from the 3-month and 6-month

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 10, 2024· MEDLINE INDUSTRIES, LP - Northfield

Recalled Item: Medline Remedy Clinical TREAT Antifungal Cream

The Issue: Labeling: Not Elsewhere Classified; Product labeling contains the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 10, 2024· BE PHARMACEUTICALS AG

Recalled Item: Fosaprepitant for Injection 150 mg per vial

The Issue: Lack of Sterility Assurance: Aseptic process simulation failure

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 8, 2024· Teva Pharmaceuticals USA, Inc

Recalled Item: Budesonide Extended-Release Tablets 9mg

The Issue: Failed Quality Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
January 5, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Rifampin Capsules USP 150mg

The Issue: Subpotent Drug and Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 5, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Rifampin Capsules USP 300mg

The Issue: Subpotent Drug and Failed Impurities/Degradation Specifications

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
January 4, 2024· Azurity Pharmaceuticals, Inc.

Recalled Item: Zenzedi (Dextroamphetamine Sulfate) CII Tablets

The Issue: Labeling: Label Mix-up

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardTerminated
Refund
January 4, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fluocinolone Acetonide Oil

The Issue: Failed Excipient Specifications: OOS for assay of Isopropyl

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund